BCL2 and neoplasm: PIC can inhibit the phosphorylation activity of Beclin-1 and hinder its binding with Bcl-2, further triggering Beclin-1-dependent autophagic signaling activation, effectively suppressing tumor progression in GC xenograft models and inducing cell apoptosis.